Navigation Links
RedVision Announces Integrated Client Workflow Platform: TitleVision2 'The Power of Two'
Date:4/27/2010

PARSIPPANY, N.J., April 27 /PRNewswire/ -- RedVision, a national provider of real property research solutions announced today the release of TitleVision2, a fully integrated production workflow solution for lenders, title underwriters, title agents, and default servicing professionals.

TitleVision2 is changing the way the real property research industry compiles, prepares and delivers real property reports and title examinations. This unique platform empowers RedVision clients to integrate and customize workflow tasks and production roles based on their individual needs. RedVision is turning high touch processes into automated functions by leveraging real estate data, ground breaking technology and more than 450 U.S. based employees and examiners.

"We are proud of our technology and the savings TitleVision2 provides each of our clients," said Brian Twibell, CEO of RedVision. "By integrating our production platform and experienced staff with our clients we enable each of them to utilize RedVision's professionals and make the best use of their staff. We are providing peace of mind that every touch point of a property report receives the highest skill level possible and quality standards are exceeded every step of the way. Creating a true strategic partnership is an unwavering goal for RedVision."  

TitleVision2 was created with "The Power of Two" in mind and the need to provide clients with reliable means to dealing with industry cycles and cost saving alternatives. The systems foundation was built from the RedVision geographically indexed title plant "TitleVision" and the internal production platform utilized by RedVision's staff. The key purpose behind the development of TitleVision2 was to supply clients with a solution for cost effective staffing and high quality reports. The system addresses an industry reality that staffing and production needs can change by the hour. At a moment's notice, clients can now select online access to the company's robust title plant while utilizing their own examination staff, or have access to the RedVision research and examination team. Clients can now completely customize the vendor relationship from order placement and research needs, to typing requirements and quality control standards all at the click of a button.

About RedVision

RedVision is an independent provider of real property research solutions, combining experts and technology to improve service levels and the bottom line. RedVision serves users of title evidence looking for relevant and accurate information to make sound business decisions relating to real property transactions. The company's revolutionary approach combines a distributed services workflow platform, a vast title plant database, and well-trained service experts to provide accurate, cost effective, and timely real property research services for its banking, title, and default and settlement service customers.


'/>"/>
SOURCE RedVision
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... DALLAS , Feb. 10, 2016  Fotona, based in ... it will launch its new ST PRO Lightwalker dental laser ... Chicago Dental Society from 25-27 February, 2016 in booth #4815. ... tissue dental laser with many of the features of the ... $49,900, the ST PRO competitive price will be very attractive ...
(Date:2/10/2016)...   Genomic Health, Inc. (Nasdaq: GHDX ) today ... ended December 31, 2015. --> --> ... compared with $69.1 million in the fourth quarter of 2014, an ... 9 percent compared with the same period in the prior year. ... $63.9 million in the fourth quarter of 2015, an increase of ...
(Date:2/10/2016)...  Cepheid (Nasdaq: CPHD ) today announced ... President and Chief Operating Officer, has been promoted ... Officer.  In his new capacity, Mr. Kocmond,s responsibilities ... Operations in addition to Manufacturing Operations, Engineering, Technical ... to report to John Bishop , Cepheid,s ...
Breaking Medicine Technology:
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... practitioner, is known locally for a series of therapeutic sessions to help Los ... their characters and in their lives. The series, known as “Mindfulness for Actors ...
(Date:2/10/2016)... ... February 10, 2016 , ... MetLoop ... revolutionary new 2.0 version at the International Roofing Expo in Orlando, Florida on ... the world's most advanced weather technology in the hands of consumers, roofing contractors, ...
(Date:2/10/2016)... ... February 10, 2016 , ... The Wickman Agency in Garland, ... the local community. Pledging to select a new beneficiary every 60 days, the ... Their goal is to bring community awareness to important local causes by forming ...
(Date:2/10/2016)... ... 2016 , ... Ongoing news of the ravages of traumatic brain injury (TBI) ... survey that takes a closer look at cases of TBI being managed by their ... TBI among the aging population, and identifies the challenges associated with their care. , ...
(Date:2/10/2016)... ... 10, 2016 , ... Armune BioScience signed a definitive agreement with ... service centers across the country. Launched in April of 2015, Apifiny is the only ... cancer. Apifiny order volume exceeded 3,000 tests in 2015. Primary care physicians and urologists ...
Breaking Medicine News(10 mins):